Portfolio Repositioning And Engineered Additives Will Create A Sustainable Future

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

27 May 25

Updated

10 Dec 25

Views

45

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

46.1%

7D

1.2%

Loading

1Y

46.1%

7D

1.2%

You can edit this narrative until Dec 11 11:05 PM. Then, changes will post as Updates.

Author's Valuation

US$68.2512.7% undervalued

AnalystConsensusTarget Fair Value

Shared on 10 Dec 25

Fair value Increased 4.60%

NGVT: Future Battery Materials Role Will Drive Stronger Long Term Upside Potential

Analysts have nudged their price target on Ingevity higher from $65.25 to $68.25, citing a modestly richer future earnings multiple that more than offsets slightly softer revenue growth and margin assumptions. What's in the News Ingevity announced that Executive Vice President and Chief Financial Officer Mary Dean Hall will transition from her role effective May 1, 2026, and remain in an advisory capacity for one year, as part of a planned leadership change.

Shared on 05 Sep 25

Fair value Increased 7.85%

Consensus analyst price targets for Ingevity have risen to $65.25, reflecting increased confidence in continued earnings and free cash flow growth following a strong Q2 beat and improved operational outlook. Analyst Commentary Q2 earnings beat, demonstrating stronger-than-expected financial performance.

Shared on 06 Aug 25

Fair value Increased 12%

The upward revision in Ingevity's revenue growth forecasts from 2.6% to 3.7% per annum has outweighed the impact of a higher discount rate, resulting in an increased consensus analyst price target from $54.25 to $57.00. What's in the News Ingevity Corporation maintained its earnings guidance for 2025, expecting sales between $1.25 billion and $1.40 billion.

AnalystConsensusTarget Fair Value

US$68.25

12.7% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

1.14%

Chemicals revenue growth rate

0.58%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.51%

Calculation

US$385.41m

Earnings '28

x

7.71x

PE Ratio '28

=

US$2.97b

Market Cap '28

US$2.97b

Market Cap '28

/

34.83m

No. shares '28

=

US$85.28

Share Price '28

US$85.28 Share Price '28

Discounted to 2025 @ 8.57% p.a.

=

US$66.63

Fair Value '25